Stefan Braam's Biography

• Home
• |
• Agenda
  • Agenda Day 1
  • Agenda Day 2
• |

Cardiomyocytes from Pluripotent Stem Cells in Drug Discovery & Development

Tuesday, 29 March 2011 at 09:30

Add to Calendar ▼2011-03-29 09:30:002011-03-29 10:30:00Europe/LondonCardiomyocytes from Pluripotent Stem Cells in Drug Discovery and DevelopmentMedChem Europe in MunichMunichSELECTBIOenquiries@selectbiosciences.com

Human pluripotent stem cell lines, either of embryonic origin or derived from adult somatic cells like skin by reprogramming (iPS, induced Pluripotent Stem cells), are considered promising novel tools for drug toxicity screening, drug target discovery, as well as drug development.